Home Tags AveXis
The US just approved a $2.1 million treatment for a devastating disease. It’s the most expensive drug in the world.
The treatment, called Zolgensma, should last longer than a typical drug. It also has a much higher price tag.
Dispensed: Venture-backed insurance startup Bright Health’s 2018 results, a dispute between 2 drug giants, and the quest for a male birth contro...
Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
A revolutionary drug that could treat a rare and devastating disease is prohibitively expensive. But one state has a plan to pay for its potential $5 ...
A one-time treatment for a devastating rare disease could be paid for with an installment plan in Massachusetts. That could set a roadmap for the US.
FILE PHOTO: Logo of...
Novartis just handed out a $8.7 billion endorsement for new therapies that are changing how we treat genetic diseases
Novartis is acquiring gene therapy company AveXis for $8.7 billion. It's part of a wave of big bets in gene therapy, a cutting-edge area of science that has had some big advancements over the past year.